COVID Boosters Should Target Omicron BA.4/5
An FDA vaccine advisory committee recommended future COVID-19 vaccine boosters should include a SARS-CoV-2 omicron BA.4/5 component for boosters beginning in fall 2022.
Category: Products & Treatment
Products & Treatment
Latest
Products & Treatment
Latest
FDA Approves Vaxneuvance Pneumococcal Vaccine for Infants, Children
The FDA has expanded the approval for Merck's Vaxneuvance for prevention of invasive disease caused by Streptococcus pneumoniae to include children 6 weeks through 17 years of age.
Products & Treatment
Latest
Oxygen Therapy: Sorting Through the Options
One of the chief responsibilities of pulmonologists and respiratory therapists is to administer and monitor supplemental oxygen therapy.
Industry & Regulatory News
Latest
Philips Recall Expands to All V60, V60 Plus Ventilators
Philips Respironics is recalling all V60 and V60 Plus ventilators because an internal power fluctuation may cause the ventilator to shut down unintentionally either with or without any visible or audible alarms, according to an FDA recall alert.
Pharmaceuticals
Latest
NIH to Trial Dupilumab for Asthma
The National Institutes of Health has launched a clinical trial testing whether a monoclonal antibody, dupilumab, can reduce asthma attacks and improve lung function and asthma symptoms in children with poorly controlled allergic asthma who live in low-income urban neighborhoods.
Diagnostics & Testing
Latest
Just How Accurate Are Rapid Antigen Tests? Two Testing Experts Explain the Latest Data
Even though demand for COVID-19 tests greatly overwhelmed supply earlier in the pandemic, rapid home tests are more available today.
Monitoring & Treatment
Latest
Dale Introduces BreezeLock Endotracheal Tube Holder
Dale Medical Products has introduced its new BreezeLock Endotracheal Tube Holder, featuring a soft, comfortable, flexible neckband with no hard plastic parts.